Revvity | PKI - Ebit



金融业
股票价格
USD 160.72
资产
USD 11.49B
现金及等价物
USD 592.8M
销售成本
USD 310.32M
流动资产
USD 1.86B
流动负债
USD 701.48M
债务
USD 2.63B
股息收益率
0.19
EBIT
USD 124.63M
EBITDA
USD 227.55M
员工
11K
EPS每股收益
USD 1.37
股本和储备
USD 7.23B
销售毛利
USD 418.58M
债务利息支出
USD 20.81M
利息收入
USD -22.99M
贷款资金
USD 2.63B
市值
USD 19.8B
净收入
USD 62.3M
营业费用
USD 604.27M
营业利润
USD 124.63M
普通股股本
USD 111.59M
PE价格收益
56.86
税前利润
USD 187.24M
销售收入
USD 729M
销售和管理费用
USD 275.33M
股票
USD 388.85M
贸易债权人
USD 163.27M
应收帐款人
USD 687.33M


Ebit 更改 日
Agilent USD 444M 45M 2026-06
Align Technology USD 193.04M 1.72M 2026-09
Bio Techne USD 55.82M 16.99M 2026-09
Bio-Rad Laboratories USD 72.6M 750.1M 2026-06
Bruker USD 83.5M 13.9M 2026-09
Celltrion KRW 20.08B 6.67B 2026-06
Charles River Laboratories USD 221.85M 101.96M 2026-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Danaher USD 1.25B 118M 2026-09
Dentsply International USD 38M 46M 2026-09
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 14.24B 2.95B 2026-09
Edwards Lifesciences USD 542.7M 23.2M 2026-09
Illumina USD 305M 45M 2026-09
Intuitive Surgical USD 1.05B 69.9M 2026-09
IQVIA Holdings USD 608M 1.99B 2026-09
Kangmei Pharma CNY -35.26M 22.54M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 418M 38.7M 2026-09
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Mesa Laboratories USD 4.45M 2.5M 2024-09
Mettler Toledo International USD 300.2M 12.65M 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Organigram Holdings CAD 5.33M 15.12M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pharma Mar EUR 7.65M 9.06M 2026-09
Qiagen NV USD 141.4M 44.52M 2026-06
Quest Diagnostics USD 479M 20M 2026-09
Quidel USD 12.1M 27.4M 2026-09
Repligen USD 24.31M 3.18M 2026-09
Revvity USD 124.63M 1.51M 2026-09
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.46B 277M 2026-09
Tilray USD -20.01M 9.34M 2025-09
Waters USD 10M 138M 2026-06
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09